GEODE CAPITAL MANAGEMENT, LLC - TRANSLATE BIO INC ownership

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$33,319,000
+74.0%
1,209,853
+4.2%
0.01%
+66.7%
Q1 2021$19,150,000
-2.0%
1,161,369
+9.6%
0.00%0.0%
Q4 2020$19,534,000
+43.6%
1,059,949
+6.0%
0.00%0.0%
Q3 2020$13,606,000
-7.4%
999,754
+22.0%
0.00%0.0%
Q2 2020$14,689,000
+151.7%
819,710
+40.1%
0.00%
+50.0%
Q1 2020$5,835,000
-34.4%
585,264
-46.5%
0.00%
+100.0%
Q4 2019$8,898,000
+76.4%
1,093,162
+114.8%
0.00%0.0%
Q3 2019$5,044,000
+1.1%
509,004
+28.9%
0.00%0.0%
Q2 2019$4,988,000
+100.9%
394,944
+62.0%
0.00%0.0%
Q1 2019$2,483,000
+41.1%
243,754
+3.8%
0.00%
Q4 2018$1,760,000
+258.5%
234,864
+378.0%
0.00%
Q3 2018$491,00049,1320.00%
Other shareholders
TRANSLATE BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 2,656,517$48,960,00010.98%
Copernicus Capital Management, LLC 12,091$223,0003.48%
FRAZIER MANAGEMENT LLC 2,182,789$40,229,0003.10%
Baupost Group 18,044,239$326,236,0003.01%
DAFNA Capital Management LLC 225,393$4,154,0001.24%
RTW INVESTMENTS, LP 2,978,427$54,892,0000.92%
MARATHON CAPITAL MANAGEMENT 143,275$2,640,0000.78%
Bain Capital Public Equity Management II, LLC 627,387$11,563,0000.59%
Artal Group S.A. 1,200,000$22,116,0000.48%
Birchview Capital, LP 30,000$553,0000.32%
View complete list of TRANSLATE BIO INC shareholders